These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37904563)

  • 1. Regulating miRNAs Expression by Resveratrol: Novel Insights based on Molecular Mechanism and Strategies for Cancer Therapy.
    Keshavarzmotamed A; Mousavi V; Masihipour N; Rahmati A; Mousavi Dehmordi R; Ghezelbash B; Alimohammadi M; Mafi A
    Curr Mol Pharmacol; 2023 Oct; ():. PubMed ID: 37904563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noncoding RNAs as Molecular Targets of Resveratrol Underlying Its Anticancer Effects.
    Wang M; Jiang S; Yu F; Zhou L; Wang K
    J Agric Food Chem; 2019 May; 67(17):4709-4719. PubMed ID: 30990036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of microRNAs expression and cellular signaling pathways through curcumin as a potential therapeutical approach against ovarian cancer: A review.
    Moazzami B; Chaichian S; Nikfar B; Arbabi Bidgoli S
    Pathol Res Pract; 2023 Jul; 247():154527. PubMed ID: 37235907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting miRNAs by natural products: A new way for cancer therapy.
    Zhang B; Tian L; Xie J; Chen G; Wang F
    Biomed Pharmacother; 2020 Oct; 130():110546. PubMed ID: 32721631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tumor effects and cellular mechanisms of resveratrol.
    Han G; Xia J; Gao J; Inagaki Y; Tang W; Kokudo N
    Drug Discov Ther; 2015 Feb; 9(1):1-12. PubMed ID: 25788047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Resveratrol in Modulating microRNAs in Human Diseases: From Cancer to Inflammatory Disorder.
    Amiri A; Mahjoubin-Tehran M; Asemi Z; Shafiee A; Hajighadimi S; Moradizarmehri S; Mirzaei HR; Mirzaei H
    Curr Med Chem; 2021; 28(2):360-376. PubMed ID: 31830882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triacetyl resveratrol upregulates miRNA‑200 and suppresses the Shh pathway in pancreatic cancer: A potential therapeutic agent.
    Fu J; Shrivastava A; Shrivastava SK; Srivastava RK; Shankar S
    Int J Oncol; 2019 Apr; 54(4):1306-1316. PubMed ID: 30720134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network Pharmacology-Based and Molecular Docking Analysis of Resveratrol's Pharmacological Effects on Type I Endometrial Cancer.
    Zhong Z; Guo X; Zheng Y
    Anticancer Agents Med Chem; 2022; 22(10):1933-1944. PubMed ID: 34773964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging roles for modulation of microRNA signatures in cancer chemoprevention.
    Neelakandan K; Babu P; Nair S
    Curr Cancer Drug Targets; 2012 Jul; 12(6):716-40. PubMed ID: 22515522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulating miRNA by natural agents as a new strategy for cancer treatment.
    Sethi S; Li Y; Sarkar FH
    Curr Drug Targets; 2013 Sep; 14(10):1167-74. PubMed ID: 23834152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol inhibits hepatic stellate cell activation by regulating autophagy and apoptosis through the SIRT1 and JNK signaling pathways.
    Zhang J; Ping J; Jiang N; Xu L
    J Food Biochem; 2022 Dec; 46(12):e14463. PubMed ID: 36314441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological actions and molecular effects of resveratrol, pterostilbene, and 3'-hydroxypterostilbene.
    Tsai HY; Ho CT; Chen YK
    J Food Drug Anal; 2017 Jan; 25(1):134-147. PubMed ID: 28911531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mechanistic insight into the anticancer potentials of resveratrol: Current perspectives.
    Bhuia MS; Chowdhury R; Akter MA; Ali MA; Afroz M; Akbor MS; Sonia FA; Mubarak MS; Islam MT
    Phytother Res; 2024 May; ():. PubMed ID: 38768953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol inhibits Erk1/2-mediated adhesion of cancer cells via activating PP2A-PTEN signaling network.
    Chen X; Hu X; Li Y; Zhu C; Dong X; Zhang R; Ma J; Huang S; Chen L
    J Cell Physiol; 2019 Mar; 234(3):2822-2836. PubMed ID: 30066962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol analogue, HS-1793, induces apoptotic cell death and cell cycle arrest through downregulation of AKT in human colon cancer cells.
    Kim DH; Kim MJ; Sung B; Suh H; Jung JH; Chung HY; Kim ND
    Oncol Rep; 2017 Jan; 37(1):281-288. PubMed ID: 27840966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of miRNA Expression through plant extracts and compounds against breast cancer: Mechanism and translational significance.
    Ahmed F; Ijaz B; Ahmad Z; Farooq N; Sarwar MB; Husnain T
    Phytomedicine; 2020 Mar; 68():153168. PubMed ID: 31982837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anticancer effects of resveratrol: modulation of transcription factors.
    Whitlock NC; Baek SJ
    Nutr Cancer; 2012; 64(4):493-502. PubMed ID: 22482424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Angiogenic Effects of Phytochemicals on miRNA Regulating Breast Cancer Progression.
    Varghese E; Liskova A; Kubatka P; Mathews Samuel S; Büsselberg D
    Biomolecules; 2020 Jan; 10(2):. PubMed ID: 32012744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol: from enhanced biosynthesis and bioavailability to multitargeting chronic diseases.
    Pannu N; Bhatnagar A
    Biomed Pharmacother; 2019 Jan; 109():2237-2251. PubMed ID: 30551481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.